https://www.selleckchem.com/pr....oducts/as1842856.htm
These are promising findings for the development of new effective, low-cost concurrent cancer therapy.Emerging evidence in clinical and preclinical studies indicates that success of immunotherapies can be impacted by the state of the microbiome. Understanding the role of the microbiome during immune-targeted interventions could help us understand heterogeneity of treatment success, predict outcomes, and develop additional strategies to improve efficacy. In this review, we discuss key studies that reveal reciprocal interactions between
Curtir
Comentario
Compartilhar
